{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:58:14Z","timestamp":1790787494291,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pulmonary fibrosis is a progressive scarring disorder of the lung with dismal prognosis and no curative therapy. Clusterin, an extracellular chaperone and regulator of cell functions, is reduced in bronchoalveolar lavage fluid of patients with pulmonary fibrosis. However, its distribution and role in normal and fibrotic human lung are incompletely characterized. Immunohistochemical localization of clusterin revealed strong staining associated with fibroblasts in control lung and morphologically normal areas of fibrotic lung but weak or undetectable staining in fibrotic regions and particularly fibroblastic foci. Clusterin also co-localized with elastin in vessel walls and additionally with amorphous elastin deposits in fibrotic lung. Analysis of primary lung fibroblast isolates <jats:italic>in vitro<\/jats:italic> confirmed the down-regulation of clusterin expression in fibrotic compared with control lung fibroblasts and further demonstrated that TGF-\u03b2<jats:sub>1<\/jats:sub> is capable of down-regulating fibroblast clusterin expression. shRNA-mediated down-regulation of clusterin did not affect TGF-\u03b2<jats:sub>1<\/jats:sub>-induced fibroblast-myofibroblast differentiation but inhibited fibroblast proliferative responses and sensitized to apoptosis. Down-regulation of clusterin in fibrotic lung fibroblasts at least partly due to increased TGF-\u03b2<jats:sub>1<\/jats:sub> may therefore represent an appropriate but insufficient response to limit fibroproliferation. Reduced expression of clusterin in the lung may also limit its extracellular chaperoning activity contributing to dysregulated deposition of extracellular matrix proteins.<\/jats:p>","DOI":"10.1038\/s41598-018-20316-1","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T15:17:38Z","timestamp":1516807058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Lizzy","family":"Peix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona C.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet K.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby M.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"McAnulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"20316_CR1","first-page":"517","volume":"345","author":"EB Meltzer","year":"2008","unstructured":"Meltzer, E. B. & Noble, P. W. Idiopathic pulmonary fibrosis. Orphanet J. Rare Dis. 345, 517\u2013525 (2008).","journal-title":"Orphanet J. Rare Dis."},{"key":"20316_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1183\/09031936.00185114","volume":"46","author":"J Hutchinson","year":"2015","unstructured":"Hutchinson, J., Fogarty, A., Hubbard, R. & McKeever, T. Global incidence and mortality of idiopathic pulmonary fibrosis: A systematic review. Eur. Respir. J. 46, 795\u2013806 (2015).","journal-title":"Eur. Respir. J."},{"key":"20316_CR3","doi-asserted-by":"crossref","unstructured":"Kreuter, M., Bonella, F., Wijsenbeek, M., Maher, T. M. & Spagnolo, P. Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and FuturePerspectives. Biomed Res. Int. 2015, (2015).","DOI":"10.1155\/2015\/329481"},{"key":"20316_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1183\/09031936.00069307","volume":"30","author":"TM Maher","year":"2007","unstructured":"Maher, T. M., Wells, A. U. & Laurent, G. J. Idiopathic pulmonary fibrosis: Multiple causes and multiple mechanisms? Eur. Respir. J. 30, 835\u2013839 (2007).","journal-title":"Eur. Respir. J."},{"key":"20316_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga, J. & Abraham, D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117, 557\u2013567 (2007).","journal-title":"J. Clin. Invest."},{"key":"20316_CR6","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/art.38702","volume":"4","author":"EL Herzog","year":"2014","unstructured":"Herzog, E. L. et al. Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis: How Similar and Distinct? Arthritis Rheumatol. 4, 1967\u20131978 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"20316_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/thx.2006.062836","volume":"61","author":"J Gribbin","year":"2006","unstructured":"Gribbin, J. et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 61, 980\u20135 (2006).","journal-title":"Thorax"},{"key":"20316_CR8","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King","year":"2014","unstructured":"King, T. E. et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2083\u201392 (2014).","journal-title":"N. Engl. J. Med."},{"key":"20316_CR9","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi, L. et al. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. N. Engl. J. Med. 370, 2071\u201382 (2014).","journal-title":"N. Engl. J. Med."},{"key":"20316_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.biocel.2006.11.005","volume":"39","author":"RJ McAnulty","year":"2007","unstructured":"McAnulty, R. J. Fibroblasts and myofibroblasts: Their source, function and role in disease. Int. J. Biochem. Cell Biol. 39, 666\u2013671 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"20316_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1164\/rccm.200905-0659OC","volume":"182","author":"TH Kim","year":"2010","unstructured":"Kim, T. H. et al. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: Antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Am. J. Respir. Crit. Care Med. 182, 633\u2013642 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20316_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1681\/ASN.2011010048","volume":"23","author":"GS Jung","year":"2012","unstructured":"Jung, G. S. et al. Clusterin attenuates the development of renal fibrosis. J. Am. Soc. Nephrol. 23, 73\u201385 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"20316_CR13","doi-asserted-by":"crossref","unstructured":"Gangadharan, B. et al. Discovery of novel biomarker candidates for liver Fibrosis in Hepatitis C patients: A preliminary study. PLoS One 7, (2012).","DOI":"10.1371\/journal.pone.0039603"},{"key":"20316_CR14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s00335-005-0179-8","volume":"17","author":"AK Greer","year":"2006","unstructured":"Greer, A. K. et al. Gene expression analysis in a canine model of X-linked Alport syndrome. Mamm. Genome 17, 976\u2013990 (2006).","journal-title":"Mamm. Genome"},{"key":"20316_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/1357-2725(95)00027-M","volume":"27","author":"ME Rosenberg","year":"1995","unstructured":"Rosenberg, M. E. & Silkensen, J. Clusterin: Physiologic and pathophysiologic considerations. International Journal of Biochemistry and Cell Biology 27, 633\u2013645 (1995).","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"20316_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/apha.12352","volume":"213","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells. Acta Physiol. 213, 505\u2013518 (2015).","journal-title":"Acta Physiol."},{"key":"20316_CR17","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.4049\/jimmunol.177.9.6471","volume":"177","author":"V Devauchelle","year":"2006","unstructured":"Devauchelle, V. et al. Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J. Immunol. 177, 6471\u20139 (2006).","journal-title":"J. Immunol."},{"key":"20316_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/1097-4652(200102)186:2<210::AID-JCP1019>3.0.CO;2-N","volume":"186","author":"J Millis","year":"2001","unstructured":"Millis, J., Luciani, M., McCue, H. M., Rosenberg, M. E. & Moulson, C. L. Clusterin regulates vascular smooth muscle cell nodule formation and migration. J. Cell. Physiol. 186, 210\u20139 (2001).","journal-title":"J. Cell. Physiol."},{"key":"20316_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbrc.2004.04.163","volume":"319","author":"Y Miwa","year":"2004","unstructured":"Miwa, Y., Takahashi-Yanaga, F., Morimoto, S. & Sasaguri, T. Involvement of clusterin in 15-deoxy-delta12,14-prostaglandin J2-induced vascular smooth muscle cell differentiation. Biochem. Biophys. Res. Commun. 319, 163\u20138 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"20316_CR20","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1152\/ajprenal.00410.2013","volume":"306","author":"CYC Nguan","year":"2014","unstructured":"Nguan, C. Y. C., Guan, Q., Gleave, M. E. & Du, C. Promotion of cell proliferation by clusterin in the renal tissue repair phase after ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 306, 724\u2013733 (2014).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"20316_CR21","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/WNR.0b013e328010ac99","volume":"17","author":"YJ Shin","year":"2006","unstructured":"Shin, Y. J. et al. Clusterin enhances proliferation of primary astrocytes through extracellular signal-regulated kinase activation. Neuroreport 17, 1871\u20135 (2006).","journal-title":"Neuroreport"},{"key":"20316_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1291","volume":"7","author":"H Zhang","year":"2005","unstructured":"Zhang, H. et al. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7, 909\u201315 (2005).","journal-title":"Nat. Cell Biol."},{"key":"20316_CR23","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1021\/bi952981b","volume":"35","author":"KB Reddy","year":"1996","unstructured":"Reddy, K. B., Jin, G., Karode, M. C., Harmony, J. A. & Howe, P. H. Transforming growth factor \u03b2 (TGF\u03b2)-induced nuclear localization of apolipoprotein J\/clusterin in epithelial cells. Biochemistry 35, 6157\u20136163 (1996).","journal-title":"Biochemistry"},{"key":"20316_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.yexcr.2006.12.010","volume":"313","author":"Y Itahana","year":"2007","unstructured":"Itahana, Y. et al. Regulation of clusterin expression in mammary epithelial cells. Exp. Cell Res. 313, 943\u201351 (2007).","journal-title":"Exp. Cell Res."},{"key":"20316_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1006\/excr.1998.4378","volume":"247","author":"Y Wegrowski","year":"1999","unstructured":"Wegrowski, Y. et al. Transforming growth factor beta-1 up-regulates clusterin synthesis in thyroid epithelial cells. Exp. Cell Res. 247, 475\u2013483 (1999).","journal-title":"Exp. Cell Res."},{"key":"20316_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1021\/bi951880a","volume":"35","author":"KB Reddy","year":"1996","unstructured":"Reddy, K. B., Karode, M. C., Harmony, A. K. & Howe, P. H. Interaction of transforming growth factor beta receptors with apolipoprotein J\/clusterin. Biochemistry 35, 309\u2013314 (1996).","journal-title":"Biochemistry"},{"key":"20316_CR27","doi-asserted-by":"publisher","first-page":"15953","DOI":"10.1021\/bi002189x","volume":"39","author":"S Poon","year":"2000","unstructured":"Poon, S., Easterbrook-Smith, S. B., Rybchyn, M. S., Carver, J. A. & Wilson, M. R. Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry 39, 15953\u201360 (2000).","journal-title":"Biochemistry"},{"key":"20316_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2559.2009.03258.x","volume":"54","author":"A Aigelsreiter","year":"2009","unstructured":"Aigelsreiter, A. et al. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis. Histopathology 54, 561\u201370 (2009).","journal-title":"Histopathology"},{"key":"20316_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.bbadis.2012.10.005","volume":"1832","author":"NC Henderson","year":"2013","unstructured":"Henderson, N. C. & Sheppard, D. Integrin-mediated regulation of TGF\u03b2 in fibrosis. Biochim. Biophys. Acta - Mol. Basis Dis. 1832, 891\u2013896 (2013).","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"20316_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1083\/jcb.124.1.171","volume":"124","author":"J Taipale","year":"1994","unstructured":"Taipale, J., Miyazono, K., Heldin, C. H. & Keski-Oja, J. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J. Cell Biol. 124, 171\u2013181 (1994).","journal-title":"J. Cell Biol."},{"key":"20316_CR31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/hc3701.095583","volume":"104","author":"M Miyata","year":"2015","unstructured":"Miyata, M. et al. Muscle Cells After Vascular Injury. Circulation 104, 1407\u20131413 (2015).","journal-title":"Circulation"},{"key":"20316_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1164\/rccm.200905-0674OC","volume":"182","author":"TM Maher","year":"2010","unstructured":"Maher, T. M. et al. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 182, 73\u201382 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20316_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/path.1531","volume":"202","author":"YP Moodley","year":"2004","unstructured":"Moodley, Y. P. et al. Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis. J. Pathol. 202, 486\u2013495 (2004).","journal-title":"J. Pathol."},{"key":"20316_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.bbrc.2014.02.071","volume":"445","author":"BH Kang","year":"2014","unstructured":"Kang, B. H. et al. Clusterin stimulates the chemotactic migration of macrophages through a pertussis toxin sensitive G-protein-coupled receptor and G\u03b2\u03b3-dependent pathways. Biochem. Biophys. Res. Commun. 445, 645\u2013650 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"20316_CR35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1165\/ajrcmb.13.4.7546780","volume":"13","author":"JC Bonner","year":"1995","unstructured":"Bonner, J. C., Badgett, A., Lindroos, P. M. & Osornio-Vargas, R. Transforming growth factor beta 1 downregulates the platelet-derived growth factor alpha-receptor subtype on human lung fibroblasts in vitro. Am J Respir Cell Mol Biol 13, 496\u2013505 (1995).","journal-title":"Am J Respir Cell Mol Biol"},{"key":"20316_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1165\/ajrcmb\/8.5.468","volume":"8","author":"AR Osornio-Vargas","year":"1993","unstructured":"Osornio-Vargas, A. R. et al. Early-passage rat lung fibroblasts do not migrate in vitro to transforming growth factor-beta. Am. J. Respir. Cell Mol. Biol. 8, 468\u201371 (1993).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"20316_CR37","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1667\/0033-7587(2003)159[0805:IBACCO]2.0.CO;2","volume":"159","author":"H Tada","year":"2003","unstructured":"Tada, H. et al. Increased binding and chemotactic capacities of PDGF-BB on fibroblasts in radiation pneumonitis. Radiat. Res. 159, 805\u2013811 (2003).","journal-title":"Radiat. Res."},{"key":"20316_CR38","first-page":"11590","volume":"278","author":"KS Leskov","year":"2003","unstructured":"Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J. & Boothman, D. A. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11590\u201311600 (2003).","journal-title":"Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem."},{"key":"20316_CR39","doi-asserted-by":"publisher","first-page":"e75303","DOI":"10.1371\/journal.pone.0075303","volume":"8","author":"H Prochnow","year":"2013","unstructured":"Prochnow, H. et al. Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-\u03baB signaling pathway. PLoS One 8, e75303 (2013).","journal-title":"PLoS One"},{"key":"20316_CR40","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/ERC-09-0140","volume":"17","author":"F Rizzi","year":"2010","unstructured":"Rizzi, F. & Bettuzzi, S. The clusterin paradigm in prostate and breast carcinogenesis. Endocr. Relat. Cancer 17, R1\u201317 (2010).","journal-title":"Endocr. Relat. Cancer"},{"key":"20316_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/(SICI)1097-4652(199909)180:3<355::AID-JCP6>3.0.CO;2-F","volume":"180","author":"CL Moulson","year":"1999","unstructured":"Moulson, C. L. & Millis, a J. Clusterin (Apo J) regulates vascular smooth muscle cell differentiation in vitro. J. Cell. Physiol. 180, 355\u2013364 (1999).","journal-title":"J. Cell. Physiol."},{"key":"20316_CR42","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/01.ATV.0000152609.28569.e1","volume":"25","author":"A Orlandi","year":"2005","unstructured":"Orlandi, A. et al. Modulation of clusterin isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25, 348\u2013353 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"20316_CR43","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1042\/bj3210639","volume":"321","author":"RJ McAnulty","year":"1997","unstructured":"McAnulty, R. J., Hern\u00e1ndez-Rodriguez, N. A., Mutsaers, S. E., Coker, R. K. & Laurent, G. J. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem. J. 321, 639\u2013643 (1997).","journal-title":"Biochem. J."},{"key":"20316_CR44","first-page":"70","volume":"60","author":"Y Yan","year":"2013","unstructured":"Yan, Y., Luo, K., Zhang, H. & Chai, W. RNA interference-mediated secretory clusterin gene silencing inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cells. Hepatogastroenterology. 60, 70\u201375 (2013).","journal-title":"Hepatogastroenterology."},{"key":"20316_CR45","doi-asserted-by":"publisher","first-page":"12851","DOI":"10.1074\/jbc.M800403200","volume":"283","author":"H Ammar","year":"2008","unstructured":"Ammar, H. & Closset, J. L. Clusterin activates survival through the phosphatidylinositol 3-kinase\/Akt pathway. J. Biol. Chem. 283, 12851\u201361 (2008).","journal-title":"J. Biol. Chem."},{"key":"20316_CR46","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/ar2941","volume":"12","author":"S Garc\u00eda","year":"2010","unstructured":"Garc\u00eda, S., Liz, M., G\u00f3mez-Reino, J. J. & Conde, C. Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage. Arthritis Res. Ther. 12, R33 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"20316_CR47","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1083\/jcb.122.5.1119","volume":"122","author":"LE French","year":"1993","unstructured":"French, L. E. et al. Murine Clusterin: Molecular cloning and mRNA localization of a gene associated with epithelial differentiation process during embryogenesis. J. Cell Biol. 122, 1119\u20131130 (1993).","journal-title":"J. Cell Biol."},{"key":"20316_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-213X-8-2","volume":"8","author":"P Nyeng","year":"2008","unstructured":"Nyeng, P., Norgaard, Ga, Kobberup, S. & Jensen, J. FGF10 maintains distal lung bud epithelium and excessive signaling leads to progenitor state arrest, distalization, and goblet cell metaplasia. BMC Dev. Biol. 8, 2 (2008).","journal-title":"BMC Dev. Biol."},{"key":"20316_CR49","doi-asserted-by":"publisher","first-page":"e71028","DOI":"10.1371\/journal.pone.0071028","volume":"8","author":"D Zheng","year":"2013","unstructured":"Zheng, D. et al. A cellular pathway involved in clara cell to alveolar type II cell differentiation after severe lung injury. PLoS One 8, e71028 (2013).","journal-title":"PLoS One"},{"key":"20316_CR50","first-page":"755","volume":"16","author":"N Gassler","year":"2001","unstructured":"Gassler, N. et al. Expression of clusterin in Crohn\u2019s disease of the terminal ileum. Histol. Histopathol. 16, 755\u2013762 (2001).","journal-title":"Histol. Histopathol."},{"key":"20316_CR51","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1371\/journal.pmed.0050062","volume":"5","author":"M Selman","year":"2008","unstructured":"Selman, M., Pardo, A. & Kaminski, N. Idiopathic pulmonary fibrosis: Aberrant recapitulation of developmental programs? PLoS Med. 5, e62 (2008).","journal-title":"PLoS Med."},{"key":"20316_CR52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2559.2005.02103.x","volume":"46","author":"GF Rozin","year":"2005","unstructured":"Rozin, G. F. et al. Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP). Histopathology 46, 413\u2013421 (2005).","journal-title":"Histopathology"},{"key":"20316_CR53","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.rmed.2013.08.008","volume":"107","author":"N Enomoto","year":"2013","unstructured":"Enomoto, N. et al. Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis. Respir. Med. 107, 1608\u20131616 (2013).","journal-title":"Respir. Med."},{"key":"20316_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12890-015-0048-5","volume":"15","author":"JH Kristensen","year":"2015","unstructured":"Kristensen, J. H. et al. Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling. BMC Pulm. Med. 15, 53 (2015).","journal-title":"BMC Pulm. Med."},{"key":"20316_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clinbiochem.2015.07.009","volume":"48","author":"JH Kristensen","year":"2015","unstructured":"Kristensen, J. H. et al. Levels of circulating MMP-7 degraded elastin are elevated in pulmonary disorders. Clin. Biochem. 48, 16\u201317 (2015).","journal-title":"Clin. Biochem."},{"key":"20316_CR56","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.2353\/ajpath.2007.061064","volume":"171","author":"E Janig","year":"2007","unstructured":"Janig, E. et al. Clusterin associates with altered elastic fibers in human photoaged skin and prevents elastin from ultraviolet-induced aggregation in vitro. Am. J. Pathol. 171, 1474\u20131482 (2007).","journal-title":"Am. J. Pathol."},{"key":"20316_CR57","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1097\/IJG.0000000000000123","volume":"23","author":"M Zenkel","year":"2014","unstructured":"Zenkel, M. & Schl\u00f6tzer-Schrehardt, U. The composition of exfoliation material and the cells involved in its production. J. Glaucoma 23, S12\u20134 (2014).","journal-title":"J. Glaucoma"},{"key":"20316_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0014-5793(02)02326-8","volume":"513","author":"S Poon","year":"2002","unstructured":"Poon, S., Treweek, T. M., Wilson, M. R., Easterbrook-Smith, S. B. & Carver, J. A. Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway. FEBS Lett. 513, 259\u2013266 (2002).","journal-title":"FEBS Lett."},{"key":"20316_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1006\/excr.2001.5358","volume":"271","author":"MM Bartl","year":"2001","unstructured":"Bartl, M. M., Luckenbach, T., Bergner, O., Ullrich, O. & Koch-Brandt, C. Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp. Cell Res. 271, 130\u201341 (2001).","journal-title":"Exp. Cell Res."},{"key":"20316_CR60","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1465-9921-6-30","volume":"6","author":"AK Reinhardt","year":"2005","unstructured":"Reinhardt, A. K., Bottoms, S. E., Laurent, G. J. & McAnulty, R. J. Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling. Respir. Res. 6, 30 (2005).","journal-title":"Respir. Res."},{"key":"20316_CR61","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0002-9440(10)64092-8","volume":"158","author":"CB Keerthisingam","year":"2001","unstructured":"Keerthisingam, C. B. et al. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 158, 1411\u20131422 (2001).","journal-title":"Am. J. Pathol."},{"key":"20316_CR62","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1476-5381.2009.00387.x","volume":"158","author":"CZC Chen","year":"2009","unstructured":"Chen, C. Z. C. et al. The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. Br. J. Pharmacol. 158, 1196\u2013209 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"20316_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5966\/sctm.2011-0029","volume":"3","author":"L Rodriguez-Menocal","year":"2012","unstructured":"Rodriguez-Menocal, L., Salgado, M., Ford, D. & Van Badiavas, E. Stimulation of skin and wound fibroblast migration by mesenchymal stem cells derived from normal donors and chronic wound patients. Stem Cells Transl Med 3, 221\u2013229 (2012).","journal-title":"Stem Cells Transl Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20316-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20316-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20316-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:39:21Z","timestamp":1671586761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20316-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["20316"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-20316-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"assertion":[{"value":"29 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.M.M. and R.J.M. are members of the GlaxoSmithKline CRAFT Consortium and have received institutional academic-industry funding from G.S.K. L.P. and J.K.S. are employees of GlaxoSmithKline. The authors have no other competing financial interests related to the work presented in the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1906"}}